Northwest Biotherapeutics (NWBO) Other Working Capital Changes (2019 - 2025)
Northwest Biotherapeutics' Other Working Capital Changes history spans 10 years, with the latest figure at $62000.0 for Q4 2025.
- Quarterly results put Other Working Capital Changes at $62000.0 for Q4 2025, up 247.62% from a year ago — trailing twelve months through Dec 2025 was $93000.0 (up 45.31% YoY), and the annual figure for FY2025 was $93000.0, up 45.31%.
- Other Working Capital Changes for Q4 2025 was $62000.0 at Northwest Biotherapeutics, up from -$8000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $125000.0 in Q4 2023 to a low of -$42000.0 in Q2 2021.
- The 5-year median for Other Working Capital Changes is $36000.0 (2022), against an average of $28000.0.
- The sharpest move saw Other Working Capital Changes tumbled 171.19% in 2021, then soared 275.0% in 2022.
- Year by year, Other Working Capital Changes stood at $27000.0 in 2021, then skyrocketed by 37.04% to $37000.0 in 2022, then soared by 237.84% to $125000.0 in 2023, then plummeted by 133.6% to -$42000.0 in 2024, then surged by 247.62% to $62000.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods came in at $62000.0, -$8000.0, and $58000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.